1-47225560-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001290403.2(TAL1):c.329C>T(p.Ala110Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000258 in 1,280,538 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001290403.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAL1 | NM_001290403.2 | c.329C>T | p.Ala110Val | missense_variant | 3/5 | ENST00000691006.1 | NP_001277332.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAL1 | ENST00000691006.1 | c.329C>T | p.Ala110Val | missense_variant | 3/5 | NM_001290403.2 | ENSP00000510655 | P1 | ||
TAL1 | ENST00000294339.3 | c.329C>T | p.Ala110Val | missense_variant | 2/4 | 1 | ENSP00000294339 | P1 | ||
TAL1 | ENST00000371884.6 | c.329C>T | p.Ala110Val | missense_variant | 3/5 | 1 | ENSP00000360951 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151946Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000248 AC: 28AN: 1128592Hom.: 0 Cov.: 32 AF XY: 0.0000296 AC XY: 16AN XY: 540538
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151946Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74212
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.329C>T (p.A110V) alteration is located in exon 2 (coding exon 1) of the TAL1 gene. This alteration results from a C to T substitution at nucleotide position 329, causing the alanine (A) at amino acid position 110 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at